The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 No. 349

SCHEDULE 2 U.K. Applications in respect of pharmaceutical lists and the procedures to be followed

PART 4 U.K. Determination and deferral of applications

Flexibility with regard to determining or deferring applications U.K.

22.—(1) Except in so far as these Regulations provide to the contrary, [F1 NHS England] is to determine or defer routine and excepted applications in such manner (including with regard to procedures) as it sees fit.

(2) [F1 NHS England] may determine a routine or excepted application without hearing any oral representations, if it considers that oral representations are unnecessary.

(3) Where appropriate, [F1 NHS England] may if it thinks fit consider 2 or more applications together and in relation to each other, but where it does so, it must give notice to the applicants of its intention to do so (if it has not already done so under Part 3).

Textual Amendments

F1 Words in Regulations substituted (6.11.2023) by The Health and Care Act 2022 (Further Consequential Amendments) (No. 2) Regulations 2023 (S.I. 2023/1071), reg. 1(1), Sch. para. 1